PATENT CLAIM ANALYSIS

Application Number: 16002364
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2019-01
Patent Classification: ["424", "137100"]

Abstract:
The invention generally relates to antibodies that bind to human folate receptor and diagnostic assays for folate receptor 1-based therapies. Methods of using the antibodies to monitor therapy are further provided.

Claim (Index 102):
The method of  claim 93 , wherein said cancer is selected from the group consisting of cervical cancer, ovarian cancer, brain cancer, breast cancer, uterine cancer, endometrial cancer, pancreatic cancer, renal cancer, lung cancer, and cancer of the peritoneum.

Metadata:
- Claim Count in Document: 86.0
- Percentile: 94.0
- Lexical Diversity: 1.22222
- Patent Class: 424.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15473008', '14473828', '14921596', '15620117', '14015653']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8168607812193367
- 35 USC 102 Novelty (BERT): 0.6365672802973156
- Combined Prediction Score: 0.7988314311271346
- Mean Citation Score: 555.782786
- Max Citation Score: 684.2430400000002
- Similarity Product: 532.4517303262045

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test